华海药业: 浙江华海药业股份有限公司第八届监事会第二十一次临时会议决议公告

Core Points - The company held its 21st temporary meeting of the 8th Supervisory Board on May 21, 2025, where all three attending supervisors unanimously approved the proposal to open a special account for temporarily supplementing working capital with idle raised funds [1][2] - The company plans to use up to 181 million yuan of idle raised funds to temporarily supplement its working capital, ensuring compliance with regulatory requirements and protecting investors' rights [2] Group 1 - The meeting was legally valid with three supervisors present, meeting the required quorum [1] - The proposal to open a special account for the management of idle raised funds was passed with a unanimous vote of 3 in favor [1][2] - The company will sign a regulatory agreement with the sponsoring institution and the bank to oversee the storage and use of the raised funds [2]